327 (Ticlopidine Hydrochloride 250 mg)
Pill with imprint 327 is White, Elliptical / Oval and has been identified as Ticlopidine Hydrochloride 250 mg. It is supplied by Caraco Pharmaceutical Laboratories.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 327
Ticlopidine Hydrochloride
- Imprint:
- 327
- Strength:
- 250 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 57664-0327
- Inactive Ingredients:
-
- microcrystalline cellulose
- magnesium silicate
- pregelatinized corn starch
- polyethylene glycol
- hypromelloses
- titanium dioxide
- polysorbate 80
- polyethylene glycol 400
Note: Inactive ingredients may vary.
More about ticlopidine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- En Español
- Drug class: platelet aggregation inhibitors
Consumer resources
Other brands: Ticlid
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
